Join
Live feed
·
INSIDERFilingvia Quantisnow
Candel Therapeutics Inc. logo

Chief Executive Officer Tak Paul Peter exercised 125,000 shares at a strike of $1.55 and sold $3,160,783 worth of shares (280,245 units at $11.28) as part of a pre-agreed trading plan, decreasing direct ownership by 58% to 113,321 units (SEC Form 4)

ByQuantisnow·Wall Street's wire, on your screen.

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track CADL (Candel Therapeutics Inc.) and more on Quantisnow.